drugset / Trial / NCT01287806

Ulinastatin in Inhalation Lung Injury

NCT01287806

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and effect of ulinastatin in inhalation lung injury patients.

Timeline

Start
2011-02
Primary completion
2012-12
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ulinastatin Protein / enzyme biologic Intravenous

Indications

No indication recorded.